Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2025-12-24 @ 9:25 PM
NCT ID:
NCT01783132
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18, ≤64 years
* Physician-diagnosis of asthma
* Regular inhaled budesonide (Giona Easyhaler, Pulmicort Turbuhaler, Novopulmon Novolizer or Symbicort Turbuhaler) treatment since at least 6 months
* Verified allergy to at least one airborne perennial allergen after objective testing (ImmunoCAP Rapid Asthma/Rhinitis Adult)
* ACQ \>1.0
* Can read and understand the Swedish language
* Written informed consent signed
Exclusion Criteria:
* Regular tobacco use within past 6 months
* ≥10 pack-years smoking history
* Keeping a furred pet at home
* Treatment with Singulair
* \>4 prednisolone courses last 12 months
* Ongoing pregnancy or lactation
* Participation in another clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT01783132
Study Brief:
Protocol Section:
NCT01783132